← Open Payments lookup

KRISTINA WOOD: Open Payments

NPI 1215441589 · MAGEE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$514 in 26 payments from 10 companies in 2025. Trend: 2023 $270 · 2024 $439 · 2025 $514

Food & beverage: $514
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$164
Novo Nordisk Inc5$95
Lilly USA, LLC4$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
ABBVIE INC.2$29
Sumitomo Pharma America, Inc.1$20
Phathom Pharmaceuticals, Inc.2$20
Inari Medical, Inc.1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$15
Axsome Therapeutics, Inc.1$13

Products named: AIRSUPRA, Ozempic, JARDIANCE, MOUNJARO, CAPLYTA, VRAYLAR, GEMTESA, VOQUEZNA.

Industry payments across MS — which companies pay providers there.